1991
DOI: 10.1097/00003086-199103000-00015
|View full text |Cite
|
Sign up to set email alerts
|

Radiocolloids in the Management of Hemophilic Arthropathy in Children and Adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
50
0
1

Year Published

1998
1998
2023
2023

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(53 citation statements)
references
References 0 publications
2
50
0
1
Order By: Relevance
“…The synovial activity in end-stage haemophilic joints goes on increasing despite dramatic bone and cartilage loss (23). It has been well known that, despite its clinical efficacy, RS does not prevent progressive severe joint degeneration in hemophilic joints as seen on both plain radiography and MRI (25,26,27,28,29,30,31,32) and our findings are also in congruence with this result as there were no significant difference between the mean scores of MRI and plain X-ray measurements before and after the procedure. …”
Section: Discussionsupporting
confidence: 90%
“…The synovial activity in end-stage haemophilic joints goes on increasing despite dramatic bone and cartilage loss (23). It has been well known that, despite its clinical efficacy, RS does not prevent progressive severe joint degeneration in hemophilic joints as seen on both plain radiography and MRI (25,26,27,28,29,30,31,32) and our findings are also in congruence with this result as there were no significant difference between the mean scores of MRI and plain X-ray measurements before and after the procedure. …”
Section: Discussionsupporting
confidence: 90%
“…Radionecrosis was the most severe symptom reported in five cases [47, 49, 50], although three cases reported needle track necrosis that resolved spontaneously [47]. The results and references are summarised in Table 3.…”
Section: Resultsmentioning
confidence: 99%
“…These agents vary with regard to size, half-life and emission properties-see Table I (Ingrand, 1973;Winston et al, 1973). The ideal agent should emit b-rays (which have a relatively shallow depth of penetration) and have a short halflife (Erken, 1991). The radionucleotide should be of a size that balances the risk of leakage, with a particle that is too small, with the risk of poor synovial distribution, with a particle that is too big (Erken, 1991).…”
Section: Radionucleotide Synovectomymentioning
confidence: 99%
“…The ideal agent should emit b-rays (which have a relatively shallow depth of penetration) and have a short halflife (Erken, 1991). The radionucleotide should be of a size that balances the risk of leakage, with a particle that is too small, with the risk of poor synovial distribution, with a particle that is too big (Erken, 1991). Given these considerations, there remains controversy as to which agent is optimal for radionucleotide synovectomy.…”
Section: Radionucleotide Synovectomymentioning
confidence: 99%
See 1 more Smart Citation